Tagrisso 80 MG tablet 30S
Ended Awarded
- Contract number
- SPE2DB25FUQQT
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $127,951
Award facts
- Contract value 100% obligated
- $127,950.84 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at approximately $128K to AmerisourceBergen Drug Corp for the supply of Tagrisso 80 mg tablets (30-count units). This competitively awarded, firm fixed-price contract contains no set-aside designation and is scheduled for completion by October 16, 2025. The contract was awarded on September 24, 2025, with performance occurring at the contractor's corporate headquarters in Conshohocken, Pennsylvania. Tagrisso (osimertinib) is a targeted cancer therapy used primarily for non-small cell lung cancer treatment, representing a critical pharmaceutical supply need within the federal military healthcare system.
This delivery order is issued under AmerisourceBergen Drug Corp's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999 through December 2026. As a major pharmaceutical distributor serving federal healthcare systems, AmerisourceBergen Drug Corp supplies an extensive portfolio of medications and medical supplies to support military healthcare programs globally. The company's substantial IDC vehicle enables flexible fulfillment of pharmaceutical needs across multiple therapeutic domains, supporting the Defense Health Agency, U.S. Coast Guard, and other government healthcare entities. This delivery order exemplifies the company's role in ensuring consistent access to specialized oncology medications for the federal defense healthcare supply chain.
Quick answers
Who was awarded contract SPE2DB25FUQQT?
SPE2DB25FUQQT was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 24, 2025.
How much is contract SPE2DB25FUQQT worth?
The government has obligated $127,951 on SPE2DB25FUQQT.
Is contract SPE2DB25FUQQT an order under another contract?
Yes. SPE2DB25FUQQT is a delivery order under SPE2DB25D3404, an indefinite delivery contract.
Was contract SPE2DB25FUQQT competed?
The extent of competition for SPE2DB25FUQQT was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award